Grace Period in Indian Patent Law
Can a Biosimilar Reference Product Trigger Infringement?
Celator’s Patent Upheld against Post-Grant Oppositions filed by Cipla and Mylan
Understanding the Difference between Section 3(d) and 3(e) through Oramed
Delhi High Court Reaffirms Inventive Step Must Be Evidence-Based, Not Assumption-Driven
Draft Version 2.0 CRI Guidelines 2025: Understanding the Changes and their Impact
Protecting IP in a Global Market: Delhi HC’s Strategic Use of Section 151 CPC
Delhi High Court Reiterates Limits on Patentability of Software-Based Inventions
MS Dhoni’s Quest to Trademark “Captain Cool”
Delhi High Court Stays Multimillion Dollar Decree against Amazon
